Cas 228401-26-1,Pyridine, 4-[[4-nitro-2-(trifluoromethyl)phenyl]thio]-

228401-26-1

Post Buying Request

Basic information

Product Name: Pyridine, 4-[[4-nitro-2-(trifluoromethyl)phenyl]thio]-
Synonyms:
CAS NO:228401-26-1
Molecular Formula: C12H7F3N2O2S
Molecular Weight: 300.261
EINECS: N/A
Product Categories: N/A
Mol File: 228401-26-1.mol

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: Pyridine, 4-[[4-nitro-2-(trifluoromethyl)phenyl]thio]-(CAS DataBase Reference)
NIST Chemistry Reference: Pyridine, 4-[[4-nitro-2-(trifluoromethyl)phenyl]thio]-(228401-26-1)
EPA Substance Registry System: Pyridine, 4-[[4-nitro-2-(trifluoromethyl)phenyl]thio]-(228401-26-1)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 228401-26-1(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

228401-26-1 Suppliers

Recommended suppliers

228401-26-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 228401-26-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,8,4,0 and 1 respectively; the second part has 2 digits, 2 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 228401-26:
(8*2)+(7*2)+(6*8)+(5*4)+(4*0)+(3*1)+(2*2)+(1*6)=111
111 % 10 = 1
So 228401-26-1 is a valid CAS Registry Number.

228401-26-1Upstream product

228401-26-1Downstream Products

228401-26-1Relevant academic research and scientific papers

INHIBITION OF P38 KINASE ACTIVITY USING SUBSTITUTED HETEROCYCLIC UREAS

-

Page/Page column 17, (2012/03/10)

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases, other than cancer and proteolytic enzyme mediated diseases, other than cancer, and pharmaceutical compositions for use in such therapy.

Inhibition Of Raf Kinase Using Symmetrical And Unsymmetrical Substituted Diphenyl Ureas

-

Page/Page column 14, (2008/12/04)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

INHIBITION OF RAF KINASE USING SUBSTITUTED HETEROCYCLIC UREAS

-

Page/Page column 17, (2010/11/28)

Methods of treating tumors mediated by raf kinase, with substituted urea compounds, and such compounds per se.

INHIBITION OF p38 KINASE USING SYMMETRICAL AND UNSYMMETRICAL DIPHENYL UREAS

-

Page/Page column 28, (2010/02/11)

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.

Inhibition of p38 kinase using symmetrical and unsymmetrical diphenyl ureas

-

, (2008/06/13)

This invention relates to the use of a group of aryl ureas in treating cytokine mediated diseases and proteolytic enzyme mediated diseases, and pharmaceutical compositions for use in such therapy.

Inhibition of raf kinase using symmetrical and unsymmetrical substituted diphenyl ureas

-

Page 23, (2010/02/08)

This invention relates to the use of a group of aryl ureas in treating raf mediated diseases, and pharmaceutical compositions for use in such therapy.

INHIBITION OF RAF KINASE USING QUINOLYL, ISOQUINOLYL OR PYRIDYL UREAS

-

Page/Page column 8-9, (2010/11/29)

This invention relates to a group of quinolyl, isoquinolyl and pyridyl ureas, their the use in treating raf mediated diseases, and pharmaceutical compositions which contain these ureas for use in such therapy.

Heteroaryl ureas containing nitrogen hetero-atoms as p38 kinase inhibitors

-

, (2008/06/13)

This invention relates to the use of a group of heteroaryl ureas containing nitrogen in treating p38 mediated diseases, and pharmaceutical compositions for use in such therapy.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 228401-26-1